Asia Pacific

Overall consumer health is set to maintain growth in current value terms in 2023, although this is expected to be slower than in the previous three years. The pandemic has ceased to have a notable impact in Indonesia, and there are many categories…

Rising health awareness amongst consumers in India is set to lead to double-digit current value growth in consumer health in 2023. In the wake of the pandemic, people have undergone a transformative shift in their priorities, emphasising health and…

Post-pandemic 2023 saw lifted restrictions lead to the return of tourists to Hong Kong and a rebound in tourism consumption, particularly for OTC products. Mainland Chinese tourists, who were once a key consumer group for these products, began to…

Consumer health in China recorded high single-digit current value growth in 2022, mainly due to the COVID-19-related sales surge for OTC products, and this growth trend is set to continue in 2023, mainly due to rising health awareness. In terms of…

In 2023, Cambodia seems to have recovered from the COVID-19 pandemic. Meanwhile, consumer health demand is rising due to modernisation, urbanisation, and health risks from harmful chemicals. Nonetheless, challenges still exist, such as external…

In Bangladesh, consumer health faces the challenge of inflation across various categories in 2023. Meanwhile, consumer preferences are shifting towards modern medicine due to its perceived quick effectiveness, leading to a decline in demand for…

Consumer health in Azerbaijan is seeing something of a resurgence in 2023. New entrants are livening up the marketplace, and fresh medications are making their mark. The once-stringent Tariff Regulatory Authority has taken a step back, loosening the…

After seeing a weakening in its growth rate in 2020, when the pandemic first hit the region, consumer health in Asia Pacific has since been recording strong growth. Further sales increases are expected over the forecast period, driven by factors such…

The briefing introduces the Cities Households Necessities Spending Index. The index ranks 1,075 cities by household expenditure on non-discretionary items, namely food, housing, and clothing and footwear. This analysis focuses on 160 major cities.…

The Asian consumer is changing. Traditional values that served the collective in terms of both society and the family are on the wane, with COVID-19 lockdowns accelerating a new focus on individualism and the self. This report explores how Asian…

The pandemic boosted demand for analgesics in Vietnam, as consumers believed that it was necessary to store analgesics at home as a precautionary measure. Adult and paediatric acetaminophen performed particularly well in 2020 and 2021, as…

Analgesics in Uzbekistan is still developing with growth opportunities in several subcategories. Current value sales remained in double-digits in 2023 continuing the trend seen throughout the review period. Analgesics tend to be purchased in…

Towards the end of the review period, demand for analgesics was supported by the widening of the consumer base for these products as the advantages of using analgesics to manage headaches and other moderate types of pain became better known among the…

Despite a decline in the number of COVID-19 cases, demand for analgesics continued to grow in 2023. This was partly due to the revival of pre-pandemic behavioural patterns, including the cessation of mask wearing and social distancing, which meant…

The topical analgesics/anaesthetic category is poised to record the fastest growth in volume and current value terms within analgesics in 2023, and looks set to show improved results in both respects as compared to 2022. These types of products…

Despite the overall waning impact of the pandemic in South Korea, simultaneous new outbreaks of COVID-19, influenza, and the common cold (referred to as a “tripledemic” in the country) are leading to a sharp increase in the number of consumers…

Due to the high rates of vaccination amongst Singaporeans, systemic analgesics were purchased in high quantities in 2022 to fulfil the demand to self-medicate amidst post-vaccination symptoms and common cold symptoms from later variants of the…

Analgesics is expected to register moderate constant value growth in 2023. In spite of continuing very high inflation, volume growth is also expected to be healthy, and is supported by continuing population growth. Price limits on analgesics is also…

The return of consumers to their busy-pandemic lifestyles had a positive impact on demand for analgesics in Malaysia in 2023. Within this, topical analgesics/anaesthetic remained the largest subcategory, as well as being the key driver of growth.…

Analgesics is projected to continue to post fast retail volume growth over 2023. The potential for even higher growth is restricted by many households retaining stocks of analgesics purchased during the Coronavirus (COVID-19) pandemic. One clear…